Satsuma Pharmaceuticals Inc

NASDAQ:STSA   3:59:50 PM EDT
4.61
+0.04 (+0.88%)
Earnings Announcements

Satsuma Pharmaceuticals Reports Third Quarter 2021 Financial Results And Provides Corporate Update

Published: 11/09/2021 22:08 GMT
Satsuma Pharmaceuticals Inc (STSA) - Satsuma Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Satsuma Pharmaceuticals Inc - $110 Million in Cash As of September 30, 2021 Provides Runway Into Second Half of 2023.
Satsuma Pharmaceuticals Inc Qtrly Loss per Share $0.42.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.